RxDoctor Payments Data

Caitlyn Smith

Nurse Practitioner · Canton, GANPI 1124613393

Payments from drug & device makers

$3,275in general payments, 2019–2025

Across 178 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$708
  • Axsome Therapeutics, Inc.$361
  • AbbVie$309
  • Lilly USA, LLC$231
  • GSK$197
  • AstraZeneca$197
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,275 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$40,352
MounjaroTirzepatide15$19,618
FarxigaDapagliflozin Propanediol17$15,736
Rosuvastatin Calcium44$442
ProgesteroneProgesterone, Micronized14$423
Levocetirizine Dihydrochloride11$334
Atorvastatin Calcium21$295
Finasteride13$220
Levothyroxine Sodium27$207
Memantine Hcl11$203
Escitalopram Oxalate13$175
Trazodone Hcl16$159
Losartan Potassium14$146
Sertraline Hcl22$142
Metoprolol Succinate12$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$708$40,35222 claims
Lilly USA, LLCMounjaro$231$19,61815 claims
AstraZenecaFarxiga$197$15,73617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →